The financial market took a long, cautious breath on Monday...

It exhaled just enough to push stocks 1% higher after a bruising few weeks.

For a moment, the tension in the Persian Gulf seemed to ease as President Donald Trump announced a five-day postponement of strikes against Iranian power plants. Trump cited "constructive talks" and a potential nuclear breakthrough.

Although Iran was quick to deny any direct or indirect contact with the U.S. administration, it didn't matter. The mere suggestion of a pause was enough to spark a much-overdue relief rally. (Though markets then reverted and finished yesterday slightly lower.)

We'll let the news outlets keep you updated on the ever-changing situation in the Middle East. That isn't our focus today. What we're keeping tabs on is a silent threat in this geopolitical chess match...

Inflation.

While the headlines focus on missiles and diplomatic denials, another story is being written in the cost of moving goods across the globe. The strife in the Persian Gulf has delivered a textbook supply shock... It's the kind of event that can transform a stable economy into a high-inflation furnace almost overnight.

The conflict is disrupting shipping operations, straining global supply chains, and driving oil prices higher. We can see the results already in the numbers...

The Baltic Dry Index, which tracks the cost of moving raw materials by sea, is up 26.7% year over year.

CRB industrial prices – essentially the cost of the materials used to build everything from skyscrapers to appliances – have risen 8%.

And oil prices have surged nearly 40% in the past 30 days alone.

These are all signs of renewed inflation risk.

If you looked at the February consumer price index ("CPI"), you might think we're in the clear. The headline number showed a relatively mild 2.4% growth.

However, the CPI is a rearview mirror. It tells you where we were, not where we're going.

Supply shocks tend to show up first in energy and freight... then ripple across a wider range of goods and services.

If conflict in the Persian Gulf persists, the pressure we're seeing in input and transport costs today will likely work its way into headline CPI inflation in the months ahead.

While government stats remain contained, the prices you pay at the local market tell a different story. Below you'll see my internal inflation monitor – from my Income Intelligence newsletter – which tracks prices on everything from oil to electricity to even a men's bike at Walmart.

As you can see, my monitor shows we're in an inflationary environment...

Twelve of our 19 measures signal inflation at the moment... And things might get worse if the conflict drags on.

Of course, the market cares about inflation because of interest rates. When inflation rises, the Federal Reserve has a harder time justifying rate cuts. And if inflation gets too high, the Fed might raise rates, as it did in 2022 and 2023.

This is important because high interest rates are kryptonite for the stock market.

They make borrowing more expensive for companies, raise mortgage and credit-card costs for consumers, and, most importantly, reduce the present value of future corporate earnings. When rates are high, investors demand more immediate profits and lower valuations.

The conflict in the Middle East seems to change just about every day. But while markets may have celebrated a five-day reprieve in military action, inflation could still soar from here.

We'll keep you updated in future issues.

In the meantime, if you'd like a more in-depth look at what's going on in the market, you should check out Income Intelligence. My internal inflation monitor I shared above is just the tip of the iceberg.

Each month, I also cover which bonds offer the best yields, the top 10 trades you can make, what I think about a specific income investment, and so much more. And all of that market analysis is in addition to my usual stock recommendations.

My goal is to show you how to safely earn high income... no matter what the market is doing.

With the inflation threat getting worse by the day, that's now more important than ever. Click here for all the details on how I can help you grow your wealth.

What We're Reading... 

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
March 25, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top